New Nordic Healthbrands AB (NNH) AI Stock Analysis

• Market Cap: kr131.96M
• Dividend Yield: N/A
• Average Volume (3M): 5.45K
• Price to Earnings (P/E): 16.3
• Beta (1Y): -0.05
• Revenue Growth: 5.91%
• EPS Growth: N/A
• Country: SE
• Employees: 77
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.22
• Shares Outstanding: 6,195,200
• 10 Day Avg. Volume: 3,153
• 30 Day Avg. Volume: 5,451
• PEG Ratio: -0.50
• Price to Book (P/B): 0.92
• Price to Sales (P/S): 0.17
• P/FCF Ratio: -14.04
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: kr23.50 ▲(9.30% Upside)

New Nordic Healthbrands AB shows a stable financial position with strong revenue growth and efficient cash flow management, which are the most significant factors in the score. However, the stock's bearish technical indicators and lack of dividend yield weigh down its overall attractiveness. The absence of earnings call data and corporate events means these factors did not influence the score.

Positive Factors

Revenue Growth

Strong revenue growth indicates increasing market demand and effective expansion strategies, supporting long-term business sustainability.

Cash Flow Generation

High free cash flow growth enhances financial flexibility, enabling reinvestment in growth opportunities and strengthening the balance sheet.

Gross Profit Margin

A high gross profit margin reflects efficient production and pricing strategies, contributing to long-term profitability and competitive advantage.

Negative Factors

Net Profit Margin

Low net profit margins indicate challenges in controlling operating expenses, which could hinder profitability and growth if not addressed.

Operational Efficiency

Modest EBIT and EBITDA margins suggest inefficiencies in operations, potentially limiting profitability and requiring strategic improvements.

Cash Conversion

Low cash conversion efficiency indicates difficulties in translating earnings into cash, which could impact liquidity and operational flexibility.

New Nordic Healthbrands AB Business Overview & Revenue Model

Company Description

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum, chewing gum, face and eye cream, and dietary supplements. It offers its products under Hair Volume, Skin Care, Beauty In & Out, and New Nordic brand names. The company sells its products through pharmacies, department stores, health stores, travel retailers, and beauty shops, as well as through online stores in 41 countries in North America, Canada, Europe, the United States, and internationally. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.

How the Company Makes Money

New Nordic Healthbrands AB generates revenue through the sale of its health and wellness products across multiple channels, including online retail, pharmacies, and health food stores. The company utilizes a direct-to-consumer model, allowing for higher margins on their products by selling directly through their website and other e-commerce platforms. Key revenue streams include sales from popular product lines tailored to specific health concerns, such as digestive health, beauty from within, and weight management. Additionally, NNH benefits from partnerships with distributors and retailers, which expand their market reach and enhance brand visibility. The growing global trend towards preventive healthcare and natural supplements also contributes significantly to NNH's earnings potential.

New Nordic Healthbrands AB Financial Statement Overview

Summary

New Nordic Healthbrands AB exhibits a stable financial position with strong revenue growth and efficient cash flow management. While the company maintains a healthy balance sheet with moderate leverage, profitability remains a challenge, as indicated by low net profit and return on equity.

Income Statement

New Nordic Healthbrands AB shows a positive revenue growth trend with a TTM (Trailing-Twelve-Months) increase of 1.66%. The gross profit margin remains strong at 64.58%, indicating efficient production. However, the net profit margin is low at 0.87%, suggesting limited profitability. The EBIT and EBITDA margins are also modest at 1.80% and 2.30% respectively, reflecting challenges in operational efficiency.

Balance Sheet

The company maintains a healthy debt-to-equity ratio of 0.37, indicating moderate leverage. The equity ratio stands at 40.14%, showing a solid equity base. However, the return on equity is relatively low at 4.95%, suggesting limited returns for shareholders.

Cash Flow

The cash flow statement reveals a strong free cash flow growth rate of 62.17% TTM, indicating improved cash generation. The operating cash flow to net income ratio is 1.36, demonstrating efficient cash conversion. However, the free cash flow to net income ratio is 0.71, which suggests room for improvement in cash profitability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	575.39M	550.31M	533.85M	487.50M	514.85M	450.06M
Gross Profit	282.18M	354.69M	348.23M	318.50M	350.05M	309.08M
EBITDA	15.55M	-1.43M	-1.94M	-2.57M	29.34M	24.47M
Net Income	8.08M	-7.70M	-6.19M	-2.82M	21.30M	17.77M
Balance Sheet
Total Assets	255.25M	248.72M	249.06M	251.67M	238.35M	191.49M
Cash, Cash Equivalents and Short-Term Investments	12.13M	15.25M	13.81M	10.70M	11.88M	10.40M
Total Debt	38.92M	39.22M	26.64M	48.35M	24.43M	1.56M
Total Liabilities	152.78M	148.19M	143.03M	139.10M	118.03M	86.68M
Stockholders Equity	102.47M	100.92M	106.03M	112.57M	120.32M	104.81M
Cash Flow
Free Cash Flow	8.73M	-6.62M	25.88M	-18.41M	-10.58M	17.80M
Operating Cash Flow	11.01M	-5.40M	28.03M	-15.45M	-7.87M	19.68M
Investing Cash Flow	-2.46M	-3.71M	-3.40M	-2.62M	-2.97M	-1.17M
Financing Cash Flow	-6.52M	10.39M	-21.17M	16.59M	12.07M	-18.39M

New Nordic Healthbrands AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 21.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NNH, the sentiment is Negative. The current price of 21.5 is below the 20-day moving average (MA) of 21.70, below the 50-day MA of 22.31, and above the 200-day MA of 21.34, indicating a bearish trend. The MACD of -0.23 indicates Positive momentum. The RSI at 45.44 is Neutral, neither overbought nor oversold. The STOCH value of 19.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NNH.

New Nordic Healthbrands AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SNX	74 Outperform	kr584.87M	27.18	―	0.51%	22.02%	127.51%
CHEF	72 Outperform	kr1.08B	20.07	―	4.05%	12.49%	116.06%
NNH	64 Neutral	kr131.96M	16.33	―	―	5.91%	―
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
HUMBLE	59 Neutral	kr3.50B	79.43	0.87%	―	5.99%	-38.16%
MSON.B	58 Neutral	kr1.29B	-323.64	-0.17%	2.34%	-2.95%	-112.90%
SKMO	56 Neutral	kr629.20M	39.57	―	2.43%	―	―